eMedicine Specialties > Dermatology > Benign Neoplasms

Milia

Author: Susan Cooper, MB, ChB, MD, MRCGP, MRCP, Consultant Dermatologist and Honorary Senior Clinical Lecturer, Department of Dermatology, Churchill Hospital, Oxford, United Kingdom
Contributor Information and Disclosures

Updated: Sep 23, 2009

Introduction

Background

Milia are very common, benign, keratin-filled cysts. Primary milia are typically seen in infants but also may occur in children and adults. Secondary milia are observed in a number of blistering disorders and following dermabrasion. Milia en plaque and multiple eruptive milia are distinct entities.

Pathophysiology

Milia are tiny epidermoid cysts. The cysts may be derived from the pilosebaceous follicle. Primary milia arise on facial skin bearing vellus hair follicles. Secondary milia result from damage to the pilosebaceous unit.

Frequency

United States

Primary milia in newborns are so common that they can be considered normal (occurring in approximately half of all infants). Multiple eruptive milia and milia en plaque are rare entities.

Race

No racial predilection is recognized for milia.

Sex

Sexual prevalence is equal for primary and secondary milia. Eruptive milia and milia en plaque occur more frequently in women.

Age

Milia occur in persons of all ages but are typically found in infants.

Clinical

History

Milia are asymptomatic. In children and adults, they usually arise around the eye. Eruptive milia, as the name suggests, have a rapid onset, often within a few weeks.

Physical

  • Skin lesions
    • Milia are superficial, uniform, pearly white to yellowish, domed lesions measuring 1-2 mm in diameter.
    • In milia en plaque, multiple milia arise on an erythematous plaque.1
  • Skin distribution
    • Primary milia, in term infants, occur on the face, especially the nose. They also may be found on the mucosa (Epstein pearls) and palate (Bohn nodules).
    • Primary milia in older children and adults develop on the face, particularly around the eyes.2
    • Milia have been observed to occur in a transverse, linear distribution along the nasal groove in some children and around the areolae.3,4
    • Secondary milia are found anywhere on the body at the sites affected by the predisposing condition.
    • Eruptive milia occur on the head, neck, and upper body.5
    • Milia en plaque manifests as distinct plaques on the head and neck. Plaques have been described in the postauricular area, unilaterally or bilaterally, the cheeks, the submandibular plaques, and on the pinna.6,7 A linear distribution has been described.8

Causes

  • Primary milia are believed to arise in sebaceous glands that are not fully developed, explaining the high prevalence in newborn infants.
  • Secondary lesions arise following blistering or trauma due to disruption of the sweat ducts. Milia have been described in association with many disorders, including bullous pemphigoid, inherited and acquired epidermolysis bullosa, bullous lichen planus, porphyria cutanea tarda, and burns. Skin trauma from dermabrasion or radiotherapy can result in milia formation.
  • Secondary milia have arisen after contact dermatitis. They have also arisen following treatment of cutaneous leishmaniasis9 and after topical nitrogen mustard ointment for plaque stage mycosis fungoides.10
  • Secondary milia have been described following potent topical corticosteroid use.11
  • Milia are a feature of a number of very rare genodermatoses (eg, Bazex-Dupr é -Christol syndrome).12 Both primary milia and multiple eruptive milia have been reported as familial disorders with autosomal dominant inheritance.13,14
  • The etiology of milia en plaque is unknown. One case has been induced by sorafenib, a multitargeted kinase inhibitor.15

More on Milia

Overview: Milia
Differential Diagnoses & Workup: Milia
Treatment & Medication: Milia
Follow-up: Milia
References
[ CLOSE WINDOW ]

References

  1. Losada-Campa A, De La Torre-Fraga C, Cruces-Prado M. Milia en plaque. Br J Dermatol. May 1996;134(5):970-2. [Medline].

  2. Ratnavel RC, Handfield-Jones SE, Norris PG. Milia restricted to the eyelids. Clin Exp Dermatol. Mar 1995;20(2):153-4. [Medline].

  3. Akinduro OM, Burge SM. Congenital milia in the nasal groove. Br J Dermatol. Jun 1994;130(6):800. [Medline].

  4. Berk DR, Bayliss SJ. Milium of the areola: a novel regional variant of primary milia. Pediatr Dermatol. Jul-Aug 2009;26(4):485-6. [Medline].

  5. Langley RG, Walsh NM, Ross JB. Multiple eruptive milia: report of a case, review of the literature, and a classification. J Am Acad Dermatol. Aug 1997;37(2 Pt 2):353-6. [Medline].

  6. Garcia Sanchez MS, Gomez Centeno P, Rosen E, Sanchez-Aguilar D, Fernandez-Redondo V, Toribio J. Milia en plaque in a bilateral submandibular distribution. Clin Exp Dermatol. Sep 1998;23(5):227-9. [Medline].

  7. Calabrese P, Pellicano R, Lomuto M, Castelvetere M. Milia en plaque. J Eur Acad Dermatol Venereol. Mar 1999;12(2):195-6. [Medline].

  8. Kautz O, Muller S, Braun-Falco M, Nashan D. Milia en plaque in a linear pattern. J Eur Acad Dermatol Venereol. Feb 27 2009;[Medline].

  9. Del Giudice P. Milia and cutaneous leishmaniasis. Br J Dermatol. May 2007;156(5):1088. [Medline].

  10. Kalayciyan A, Oguz O, Demirkesen C, Serdaroglu S, Kotogyan A. Milia in regressing plaques of mycosis fungoides: provoked by topical nitrogen mustard or not?. Int J Dermatol. Dec 2004;43(12):953-6. [Medline].

  11. Iacobelli D, Hashimoto K, Kato I, Ito M, Suzuki Y. Clobetasol-induced milia. J Am Acad Dermatol. Aug 1989;21(2 Pt 1):215-7. [Medline].

  12. Berk DR, Bayliss SJ. Milia: a review and classification. J Am Acad Dermatol. Dec 2008;59(6):1050-63. [Medline].

  13. Rutter KJ, Judge MR. Profuse congenital milia in a family. Pediatr Dermatol. Jan-Feb 2009;26(1):62-4. [Medline].

  14. Heard MG, Horton WH, Hambrick GW Jr. The familial occurrence of multiple eruptive milia. Birth Defects Orig Artic Ser. Jun 1971;7(8):333-7. [Medline].

  15. Chappell JA, Burkemper NM, Semchyshyn N. Localized dyskeratotic plaque with milia associated with sorafenib. J Drugs Dermatol. Jun 2009;8(6):573-6. [Medline].

  16. Connelly T. Eruptive milia and rapid response to topical tretinoin. Arch Dermatol. Jun 2008;144(6):816-7. [Medline].

  17. Ishiura N, Komine M, Kadono T, Kikuchi K, Tamaki K. A case of milia en plaque successfully treated with oral etretinate. Br J Dermatol. Dec 2007;157(6):1287-9. [Medline].

  18. Thami GP, Kaur S, Kanwar AJ. Surgical Pearl: Enucleation of milia with a disposable hypodermic needle. J Am Acad Dermatol. Oct 2002;47(4):602-3. [Medline].

  19. George DE, Wasko CA, Hsu S. Surgical pearl: evacuation of milia with a paper clip. J Am Acad Dermatol. Feb 2006;54(2):326. [Medline].

  20. Sandhu K, Gupta S, Handa S. CO2 laser therapy for Milia en plaque. J Dermatolog Treat. Dec 2003;14(4):253-5. [Medline].

  21. van Lynden-van Nes AM, der Kinderen DJ. Milia en plaque successfully treated by dermabrasion. Dermatol Surg. Oct 2005;31(10):1359-62, discussion 1362. [Medline].

  22. Noto G, Dawber R. Milia en plaque: treatment with open spray cryosurgery. Acta Derm Venereol. Oct-Nov 2001;81(5):370-1. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

milia, blistering disorders, milia en plaque, multiple eruptive milia, newborn skin lesions, infant skin lesions, infant plaques, epidermoid cysts, keratin-filled cysts, primary milia, secondary milia, dermabrasion, Epstein pearls, bullous pemphigoid, inherited epidermolysis bullosa, acquired epidermolysis bullosa, bullous lichen planus, porphyria cutanea tarda, burns, radiotherapy, blistering contact dermatitis, photocontact allergy to sunscreen, mycosis fungoides, genodermatosis

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Susan Cooper, MB, ChB, MD, MRCGP, MRCP, Consultant Dermatologist and Honorary Senior Clinical Lecturer, Department of Dermatology, Churchill Hospital, Oxford, United Kingdom
Susan Cooper, MB, ChB, MD, MRCGP, MRCP is a member of the following medical societies: Royal College of Physicians
Disclosure: Nothing to disclose.

Medical Editor

Marjan Garmyn, MD, PhD, Professor, Faculty of Medicine, Katholieke Universiteit Leuven, Belgium; Chair and Adjunct Head, Department of Dermatology, University of Leuven, Belgium
Disclosure: Nothing to disclose.

Pharmacy Editor

Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA
Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Association of Military Dermatologists, Texas Dermatological Society, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Jeffrey P Callen, MD, Professor of Medicine, Chief, Division of Dermatology, University of Louisville School of Medicine
Jeffrey P Callen, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and American College of Rheumatology
Disclosure: Amgen Honoraria Consulting; Abbott Honoraria Consulting; Electrical Optical Sciences Honoraria Consulting; Centocor Honoraria Consulting; Medicis Honoraria Consulting; Celgene Honoraria Consulting

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.